Trial
NCT04234360
Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Hospital, Montpellier
Collaborators
—
Condition
COPD Exacerbation
Intervention
5 days of systemic corticotherapy (prednisone)
Why stopped
low enrollment at participating centers
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-12